Hygiene protocols for the treatment of denture-related stomatitis: local and systemic parameters analysis-a randomized, double-blind trial protocol

被引:14
|
作者
Ribeiro, Adriana B. [1 ]
de Araujo, Camila B. [1 ]
Silva, Luiz Eduardo, V [2 ]
Fazan-Junior, Rubens [2 ]
Salgado, Helio C. [2 ]
Ribeiro, Aline B. [2 ]
Fortes, Caroline, V [1 ]
Bueno, Frank L. [1 ]
de Oliveira, Viviane C. [1 ]
Paranhos, Helena de F. O. [1 ]
Watanabe, Evandro [3 ]
Silva-Lovato, Claudia H. [1 ]
机构
[1] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Dent Mat & Prosthodont, Ribeirao Preto, Brazil
[2] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Physiol, Ribeirao Preto, Brazil
[3] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Restorat Dent, Ribeirao Preto, Brazil
基金
巴西圣保罗研究基金会;
关键词
Complete dentures; Biofilm; Cleansers; Candida; Stomatitis; Clinical trials; Heart diseases; CLINICAL-TRIAL; T-CELLS; CANDIDIASIS; DISEASE; SALIVA; MUC1;
D O I
10.1186/s13063-019-3854-x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background Denture-related stomatitis (DS) is chronic multifactorial inflammation, strongly related to the presence of the biofilm that is the complex structure formed by microorganisms held together by a mucus-like matrix of carbohydrate that adheres to different surfaces, including the denture surface. DS has recently been correlated with deleterious cardiovascular alterations. The potential effect of hygiene protocols in the control of DS and randomized clinical trials that address this oral condition with cardiovascular complications are important in clinical decision-making. Material/design A clinical trial, randomized, double-blind, and with parallel groups, will be conducted in Brazil The sample will consist of 100 patients without teeth in both arches, users of at least maxillary complete dentures, and diagnosed with DS, who will be allocated to groups (n = 25 per group) according to the different hygiene protocols: (1) brushing of the palate and immersion of the prosthesis in 0.25% sodium hypochlorite solution (positive control); (2) brushing of the palate and immersion of the prosthesis in 0.15% triclosan solution; (3) brushing of the palate and immersion of the prosthesis in lactose monohydrate; or (4) brushing the palate with citric acid and immersing the prosthesis in lactose monohydrate. The response variables will be heart rate variability and alteration of blood pressure (systemic level), remission of DS, removal of biofilm, reduction of microbial load (colony-forming units (CFU)), mouth and prosthesis odor level, expression of MUC1, proinflammatory cytokines, C-reactive protein (CRP), viscosity, pH and salivary flow (locally); patient-centred qualitative analysis will also be undertaken. Measurements will be performed at baseline and 10 days after the interventions. The results obtained will be statistically analyzed as pertinent, with a level of significance of 0.05. Discussion This study will provide a guideline for clinical practice regarding the use of hygiene protocols in the treatment of oral diseases (DS) mediated by biofilm. Also, it may provide evidence of correlation of oral manifestation with cardiac risk.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] The I-MICRO trial, Ilomedin for treatment of septic shock with persistent microperfusion defects: a double-blind, randomized controlled trial—study protocol for a randomized controlled trial
    Matthieu Legrand
    Hafid Ait Oufella
    Daniel De Backer
    Jacques Duranteau
    Marc Leone
    Bruno Levy
    Patrick Rossignol
    Eric Vicaut
    François Dépret
    Trials, 21
  • [42] Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy
    Langlois, Alexandra
    Lavergne, Marie-Helene
    Leroux, Helene
    Killer, Kerstin
    Azzano, Pauline
    Paradis, Louis
    Samaan, Kathryn
    Lacombe-Barrios, Jonathan
    Masse, Benoit
    Des Roches, Anne
    Begin, Philippe
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2020, 16 (01):
  • [43] Local tissue electrical parameters predict oral mucositis in HNSCC patients: A diagnostic accuracy double-blind, randomized controlled trial
    Guimaraes Sanches, Gabriela Luize
    da Silva Menezes, Agna Soares
    Santos, Laercio Ives
    Duraes, Cristina Paixao
    Fonseca, Larissa Lopes
    Baldo, Marcelo Perim
    Faria, Thais de Oliveira
    de Araujo Andrade, Luciano Alves
    Ekel, Petr Iakovlevitch
    Sousa Santos, Sergio Henrique
    Batista de Paula, Alfredo Mauricio
    Farias, Lucyana Conceicao
    D'Angelo, Marcos Flavio Silveira Vasconcelos
    Sena Guimaraes, Andre Luiz
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [44] Local tissue electrical parameters predict oral mucositis in HNSCC patients: A diagnostic accuracy double-blind, randomized controlled trial
    Gabriela Luize Guimarães Sanches
    Agna Soares da Silva Menezes
    Laércio Ives Santos
    Cristina Paixão Durães
    Larissa Lopes Fonseca
    Marcelo Perim Baldo
    Thais de Oliveira Faria
    Luciano Alves de Araújo Andrade
    Petr Iakovlevitch Ekel
    Sérgio Henrique Sousa Santos
    Alfredo Maurício Batista de Paula
    Lucyana Conceição Farias
    Marcos Flávio Silveira Vasconcelos D’Angelo
    André Luiz Sena Guimarães
    Scientific Reports, 10
  • [45] Double-blind, randomized, controlled clinical trial of the effects of diosmectite and basic fibroblast growth factor paste on the treatment of minor recurrent aphthous stomatitis
    Jiang, Xiao-Wen
    Zhang, Yi
    Zhang, Hao
    Lu, Kun
    Yang, Shou-Kang
    Sun, Guo-Liang
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2013, 116 (05): : 570 - 575
  • [46] COMPARATIVE EFFICACY OF 1% CURCUMIN NANOMICELLE GEL AND 2% CURCUMIN GEL FOR TREATMENT OF RECURRENT APHTHOUS STOMATITIS: A DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL
    Bakhshi, Mahin
    Mahboubi, Arash
    Jaafari, Mahmoud Reza
    Ebrahimi, Faezeh
    Tofangchiha, Maryam
    Alizadeh, Ahad
    JOURNAL OF EVIDENCE-BASED DENTAL PRACTICE, 2022, 22 (02)
  • [47] Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial
    Ballou, Sarah
    Kaptchuk, Ted J.
    Hirsch, William
    Nee, Judy
    Iturrino, Johanna
    Hall, Kathryn T.
    Kelley, John M.
    Cheng, Vivian
    Kirsch, Irving
    Jacobson, Eric
    Conboy, Lisa
    Lembo, Anthony
    Davis, Roger B.
    TRIALS, 2017, 18
  • [48] LOTUS: Protocol for a double-blind placebo controlled randomized trial of hemp-derived cannabidiol for the treatment of cannabis use disorder
    Bidwell, L. Cinnamon
    Martin-Willett, Renee
    Melendez, Samantha N.
    Rosa, Luiza
    Giordano, Gregory
    Hutchison, Kent E.
    Bryan, Angela D.
    PLOS ONE, 2024, 19 (09):
  • [49] Effect of Probiotics on the Gastrointestinal Symptoms and Immune Parameters in Patients with Systemic Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Marighela, Thais
    Arismendi, Maria Izabel
    Brunialti, Milena
    Kayser, Cristiane
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [50] Letrozole as co-treatment agent in ovarian stimulation antagonist protocol in poor responders: A double-blind randomized clinical trial
    Moini, Ashraf
    Lavasani, Zohreh
    Kashani, Ladan
    Mojtahedi, Maryam Farid
    Yamini, Nazila
    INTERNATIONAL JOURNAL OF REPRODUCTIVE BIOMEDICINE, 2019, 17 (09) : 653 - 660